| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Acasti Pharma (NASDAQ:ACST) reported its Q4 earnings results on Friday, June 23, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Acasti Pharma reported in-line EPS of $-0.11 versus an estimate of $-0.11.
Revenue was down $0 from the same period last year.
Last quarter the company beat on EPS by $0.02 which was followed by a 3.69% drop in the share price the next day.
To track all earnings releases for Acasti Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ACST
